MARKET

NVS

NVS

Novartis
NYSE
153.44
-0.81
-0.53%
After Hours: 153.00 -0.44 -0.29% 19:37 03/13 EDT
OPEN
154.69
PREV CLOSE
154.25
HIGH
155.96
LOW
153.18
VOLUME
1.98M
TURNOVER
--
52 WEEK HIGH
165.46
52 WEEK LOW
94.85
MARKET CAP
292.79B
P/E (TTM)
21.45
1D
5D
1M
3M
1Y
5Y
1D
Novartis Cosentyx Receives FDA Approval For Pediatric Patients Aged 12+ With Moderate To Severe Hidradenitis Suppurativa
Benzinga · 2d ago
Novartis receives FDA approval for Cosentyx for patients aged 12 and older
TipRanks · 2d ago
Novartis Cosentyx wins FDA approval for moderate to severe hidradenitis suppurativa in patients aged 12+
Reuters · 2d ago
Relay Therapeutics price target raised to $22 from $15 at Guggenheim
TipRanks · 2d ago
Viatris resolves case over use of woman’s cancer cells to advance drug research
Seeking Alpha · 3d ago
Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research
Reuters · 3d ago
Largest borrow rate increases among liquid names
TipRanks · 3d ago
BUZZ-Precision Bio rises after quarterly results beat estimates
Reuters · 3d ago
More
About NVS
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Webull offers Novartis AG (ADR) stock information, including NYSE: NVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVS stock methods without spending real money on the virtual paper trading platform.